Back
Theravance Biopharma Stock Price Chart
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!
Sell
47
TBPH
Theravance Biopharma
Last Price:
9.11
Seasonality Move:
-13.46%
7 Day Trial
ALL ACCESS PASS
$
7
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TBPH is experiencing slight selling pressure.
Theravance Biopharma Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.27 | Sell |
| 20-day SMA: | 9.33 | Sell |
| 50-day SMA: | 9.07 | Buy |
| 200-day SMA: | 9.62 | Sell |
| 8-day EMA: | 9.25 | Sell |
| 20-day EMA: | 9.26 | Sell |
| 50-day EMA: | 9.24 | Sell |
| 200-day EMA: | 9.65 | Sell |
Theravance Biopharma Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 47.4 | Sell |
| Chaikin Money Flow: | -112928 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.96 - 9.52) | Sell |
| Bollinger Bands (100): | (8.71 - 10.51) | Sell |
Theravance Biopharma Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Theravance Biopharma Stock
Is Theravance Biopharma Stock a Buy?
- Theravance Biopharma share price is 9.12 while TBPH 8-day simple moving average is 9.27, which is a Sell signal.
- The stock price of TBPH is 9.12 while Theravance Biopharma 20-day SMA is 9.33, which makes it a Sell.
- Theravance Biopharma 50-day simple moving average is 9.07 while TBPH share price is 9.12, making it a Buy technically.
- TBPH stock price is 9.12 and Theravance Biopharma 200-day simple moving average is 9.62, creating a Sell signal.
TBPH Technical Analysis vs Fundamental Analysis
Sell
47
Theravance Biopharma (TBPH)
is a Sell
Is Theravance Biopharma a Buy or a Sell?
-
Theravance Biopharma stock is rated a Sell
The current Theravance Biopharma [TBPH] share price is $9.12. The Score for TBPH is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Theravance Biopharma Stock Info
Market Cap:
439.26M
Price in USD:
9.12
Share Volume:
263.5K
Theravance Biopharma 52-Week Range
52-Week High:
11.98
52-Week Low:
8.21
Sell
47
Theravance Biopharma (TBPH)
is a Sell
Theravance Biopharma Share Price Forecast
-
What is the Theravance Biopharma stock price today?
The Theravance Biopharma stock price is 9.12 USD today. -
Will TBPH stock go up or go down?
Theravance Biopharma> share price is forecast to RISE/FALL based on technical indicators -
Is Theravance Biopharma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Theravance Biopharma is overvalued.
Is Theravance Biopharma Stock a Buy?
- Theravance Biopharma share price is 9.12 while TBPH 8-day exponential moving average is 9.25, which is a Sell signal.
- The stock price of TBPH is 9.12 while Theravance Biopharma 20-day EMA is 9.26, which makes it a Sell.
- Theravance Biopharma 50-day exponential moving average is 9.24 while TBPH share price is 9.12, making it a Sell technically.
- TBPH stock price is 9.12 and Theravance Biopharma 200-day simple moving average is 9.65, creating a Sell signal.
Fundamental Analysis of Theravance Biopharma
Is Theravance Biopharma a good investment?
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $0.50 per share.
Technical Analysis of Theravance Biopharma
Should I short Theravance Biopharma stock?
- TBPH Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Theravance Biopharma is a Buy
- Theravance Biopharma Relative Strength Index (RSI) is 47.4, which suggest Theravance Biopharma is oversold
- The Bollinger Bands (25) for Theravance Biopharma is (8.96 - 9.52), which suggest Theravance Biopharma is a Sell
- The Bollinger Bands (100) for Theravance Biopharma is (8.71 - 10.51), which suggest Theravance Biopharma is a Sell
* Theravance Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.